Guardant Health Cl Stock Fundamentals
5GH Stock | EUR 33.99 0.36 1.07% |
GUARDANT HEALTH CL fundamentals help investors to digest information that contributes to GUARDANT HEALTH's financial success or failures. It also enables traders to predict the movement of GUARDANT Stock. The fundamental analysis module provides a way to measure GUARDANT HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GUARDANT HEALTH stock.
GUARDANT |
GUARDANT HEALTH CL Company Shares Outstanding Analysis
GUARDANT HEALTH's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current GUARDANT HEALTH Shares Outstanding | 102.44 M |
Most of GUARDANT HEALTH's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GUARDANT HEALTH CL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, GUARDANT HEALTH CL has 102.44 M of shares currently outstending. This is 43.26% lower than that of the Healthcare sector and 28.22% lower than that of the Diagnostics & Research industry. The shares outstanding for all Germany stocks is 82.09% higher than that of the company.
GUARDANT HEALTH CL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GUARDANT HEALTH's current stock value. Our valuation model uses many indicators to compare GUARDANT HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GUARDANT HEALTH competition to find correlations between indicators driving GUARDANT HEALTH's intrinsic value. More Info.GUARDANT HEALTH CL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GUARDANT HEALTH's earnings, one of the primary drivers of an investment's value.GUARDANT Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GUARDANT HEALTH's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GUARDANT HEALTH could also be used in its relative valuation, which is a method of valuing GUARDANT HEALTH by comparing valuation metrics of similar companies.GUARDANT HEALTH is currently under evaluation in shares outstanding category among its peers.
GUARDANT Fundamentals
Return On Equity | -1.25 | |||
Return On Asset | -0.16 | |||
Profit Margin | (1.41) % | |||
Operating Margin | (1.15) % | |||
Shares Outstanding | 102.44 M | |||
Shares Owned By Insiders | 4.60 % | |||
Shares Owned By Institutions | 93.97 % | |||
Revenue | 430.76 M | |||
Gross Profit | 250.74 M | |||
EBITDA | (462.23 M) | |||
Net Income | (378.65 M) | |||
Cash And Equivalents | 1.79 B | |||
Cash Per Share | 17.69 X | |||
Total Debt | 1.35 B | |||
Debt To Equity | 1.60 % | |||
Current Ratio | 19.57 X | |||
Book Value Per Share | 1.63 X | |||
Cash Flow From Operations | (146.16 M) | |||
Earnings Per Share | (3.92) X | |||
Target Price | 167.38 | |||
Number Of Employees | 1.37 K | |||
Beta | 0.82 | |||
Market Capitalization | 3.03 B | |||
Z Score | 1.2 |
About GUARDANT HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GUARDANT HEALTH CL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GUARDANT HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GUARDANT HEALTH CL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. GUARDANT HEALTH operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 864 people.
Currently Active Assets on Macroaxis
Other Information on Investing in GUARDANT Stock
GUARDANT HEALTH financial ratios help investors to determine whether GUARDANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GUARDANT with respect to the benefits of owning GUARDANT HEALTH security.